Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Thames

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2007
Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiationAla Yaromina, Marie Krause, Howard Thames, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 24, 2010
Radiobiological hypoxia, histological parameters of tumour microenvironment and local tumour control after fractionated irradiationAla Yaromina, Howard Thames, Xuanjing Zhou, et al.
Plos One|December 21, 2018
Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapyNils Cordes, Michael Ney, Thomas Beleites, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2011
Diverse effects of combined radiotherapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expressionKristin Gurtner, Yvonne Deuse, Rebecca Bütof, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 14, 2015
γH2AX assay in ex vivo irradiated tumour specimens: A novel method to determine tumour radiation sensitivity in patient-derived materialApostolos Menegakis, Cläre von Neubeck, Ala Yaromina, et al.
International Journal of Radiation Oncology, Biology, Physics|January 26, 2005
Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?Deborah Kuban, Howard Thames, Larry Levy, et al.
International Journal of Radiation Oncology, Biology, Physics|January 26, 2005
Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995Patrick Kupelian, Deborah Kuban, Howard Thames, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2005
Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA eraPatrick Kupelian, Howard Thames, Larry Levy, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2003
Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995Howard Thames, Deborah Kuban, Larry Levy, et al.
Cancer Research|April 19, 2007
Therapeutic effect of rapamycin on gallbladder cancer in a transgenic mouse modelQi Wu, Kaoru Kiguchi, Toru Kawamoto, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2007
Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiationAla Yaromina, Marie Krause, Howard Thames, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 24, 2010
Radiobiological hypoxia, histological parameters of tumour microenvironment and local tumour control after fractionated irradiationAla Yaromina, Howard Thames, Xuanjing Zhou, et al.
Plos One|December 21, 2018
Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapyNils Cordes, Michael Ney, Thomas Beleites, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2011
Diverse effects of combined radiotherapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expressionKristin Gurtner, Yvonne Deuse, Rebecca Bütof, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 14, 2015
γH2AX assay in ex vivo irradiated tumour specimens: A novel method to determine tumour radiation sensitivity in patient-derived materialApostolos Menegakis, Cläre von Neubeck, Ala Yaromina, et al.
International Journal of Radiation Oncology, Biology, Physics|January 26, 2005
Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?Deborah Kuban, Howard Thames, Larry Levy, et al.
International Journal of Radiation Oncology, Biology, Physics|January 26, 2005
Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995Patrick Kupelian, Deborah Kuban, Howard Thames, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2005
Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA eraPatrick Kupelian, Howard Thames, Larry Levy, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2003
Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995Howard Thames, Deborah Kuban, Larry Levy, et al.
Cancer Research|April 19, 2007
Therapeutic effect of rapamycin on gallbladder cancer in a transgenic mouse modelQi Wu, Kaoru Kiguchi, Toru Kawamoto, et al.
Pageof 3